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Abstract
Background: Serotype K1 Klebsiella pneumoniae has emerged as an important community pathogen causing various
infections, including liver abscesses. Although serotype K1 K. pneumoniae community isolates have been reported as
susceptible to most classes of antimicrobial agents, a few cases of infection caused by extended-spectrum beta-lactamase
(ESBL)-producing serotype K1 K. pneumoniae have recently been reported in Asian countries. We identified three
ESBL-producing strains of serotype K1 K. pneumoniae and conducted a molecular characterization of their drug
resistance.
Methods: Three ESBL-producing serotype K1 K. pneumoniae ST23 strains were identified from strains in the Asian
Bacterial Bank. Antimicrobial susceptibility testing was performed using the broth microdilution method, and
ESBL production was tested by the double-disk synergy test and a confirmatory test. PCR was performed to
detect the genes for plasmid-mediated ESBL and AmpC beta-lactamases.
Results: All three strains were resistant to cefotaxime, ceftazidime, and piperacillin/tazobactam, and all were
determined to be ESBL-producers. No known ESBL genes, including blaSHV, blaTEM, blaCTX-M, blaGES, blaPER, and
blaVEB, were detected among the three strains. Of all plasmid-mediated AmpC beta-lactamase (PAB) genes,
including blaDHA-1, blaCMY, blaFOX, and blaMOX, the blaDHA-1 gene was detected in two of the strains. The PFGE
patterns revealed that the two isolates carrying blaDHA-1 were closely related (84% similarity).
Conclusions: No ESBL genes were detected among three ESBL-producing serotype K1 K. pneumoniae ST23
strains. Two strains contained the PAB gene blaDHA-1. The emergence of resistant strains of community-origin
serotype K1 K. pneumoniae has important implications for effective treatment and infection control practices.
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Background
The rates of extended-spectrum beta-lactamase (ESBL)-
production in Klebsiella pneumoniae are very high in
hospitals worldwide, and highly resistant strains such as
K. pneumoniae carbapenemase (KPC) or New Delhi
metallo-beta-lactamase (NDM)-producing K. pneumoniae
have been rapidly spreading between countries. Treatment
of infections caused by multidrug-resistant K. pneumoniae
has been a challenge, and there is increasing concern
about the economic impact of these bacteria.
Serotype K1 K. pneumoniae has been reported as the
predominant serotype among those isolates causing
liver abscesses [1, 2]. Most K1 strains isolated from
liver abscess cases belong to sequence type (ST) 23 in
Asian countries [3, 4]. Although ESBL K. pneumoniae
and KPC-producing K. pneumoniae have become
globally widespread, a distinctive characteristic of K1
K. pneumoniae ST23 has been good susceptibility to
most antibiotic classes (except ampicillin and piperacillin)
[5], however, ESBL-producing K1 K. pneumoniae strains
have begun to be reported recently [6, 7]. In this study, we
report serotype K1 K. pneumoniae strains co-producing
the plasmid-mediated AmpC beta-lactamase (PAB)
DHA-1 and ESBL.
Materials and methods
Three ESBL-producing serotype K1 K. pneumoniae
ST23 strains were identified from strains in the Asian
Bacterial Bank (Asia Pacific Foundation for Infectious
Diseases, Seoul, Korea), which had been collected
during bacteremia studies in Korea between 2006 and
2008.
In vitro antimicrobial susceptibility testing was performed
using the broth microdilution method according to the
Clinical and Laboratory Standards Institute (CLSI) guide-
lines [8]. Ten antimicrobial agents were tested, including
ampicillin (AMP), amikacin (AMI), ceftazidime (CAZ),
tetracycline (TET), cefepime (CPM), cefotaxime (CTX),
ciprofloxacin (CIP), rifampicin (RIF), and piperacillin/
tazobactam (P/T). For ESBL-positive candidates, which
presented a ceftazidime or cefotaxime minimum inhibitory
concentration (MIC) ≥2 mg/L, production of ESBL was
confirmed by the double-disk synergy test using BBL™
Sensi-Disc™ kits (Becton Dickinson, Franklin Lakes, NJ,
USA) according to CLSI guidelines [8]. Quality control for
ESBL production was performed using E. coli ATCC 25922
and K. pneumoniae ATCC 700603.
Double-disk synergy test-positive isolates were further
tested by polymerase chain reaction (PCR) and sequence
analyses to determine the gene responsible for the ESBL
phenotype in the ESBL producers. In the ESBL-producing
K. pneumoniae isolates, blaTEM, blaSHV, blaCTX-M, blaGES,
blaPER, and blaVEB genes were tested by PCR. In addition,
blaDHA-1, blaCMY, blaFOX, blaMOX, blaIMP, blaVIM, blaOXA,
and blaNDM genes were tested. The sequences were
compared with those in the GenBank nucleotide database
for subtyping.
To determine serotype K1, PCR was conducted using
a primer pair specific for magA, which is a gene specific
for the K1 antigen. The primers were chosen as previously
described: forward, 5′GGTGCTCTTTACATCATTGC-3′,
and reverse, 5′-GCAATGGCCATTTGCGT TAG-3′ [9].
Multilocus sequence typing (MLST) was conducted using
the nucleotide sequences of seven housekeeping genes
(gagA, infB, mdh, pgi, phoE, rpoB, and tonB) as previously
described [10]. For pulsed field gel electrophoresis (PFGE),
agarose-embedded bacterial genomic DNA was digested
with 20 U of XbaI. The restriction fragments were
separated by gel electrophoresis in 0.5 × Tris-borate-EDTA
buffer. Electrophoresis was performed using a CHEF
Mapper XA (Bio-Rad Laboratories, Hercules, CA, USA).
The PFGE patterns were analyzed using GelCompar II
version 6.1 (Applied Maths, Belgium).
Results
Of the 120K. pneumoniae isolates, 20 (16.7%) were ESBL-
producers. Among the ESBL-producers, only three were
determined to be serotype K1 (KPN1, KPN2, and KPN3).
Antimicrobial susceptibilities of the three isolates are
shown in Table 1. All three strains were resistant to ampi-
cillin, piperacillin-tazobactam, cefotaxime, ceftazidime, and
rifampin. Two strains (KPN2 and KPN3) were also resistant
to amikacin and ciprofloxacin. One strain (KPN2) was
resistant to imipenem. In all three strains, no ESBL genes,
including blaTEM, blaSHV, blaCTX-M, blaGES, blaPER, and
blaVEB, were detected. Among the PAB genes (blaDHA-1,
blaCMY, blaFOX, and blaMOX), only blaDHA-1 was detected
in two strains (KPN2 and KPN3). Carbapenemase genes
were also not detected in all three isolates (Table 2). Clonal
relatedness was investigated by PFGE for the two strains.
Table 1 Antimicrobial susceptibilities in K1 K. pneumoniae ST23 strains
Strain MICs and antimicrobial susceptibility
AMP P/T CTX CAZ CPM CIP AMI TET IMI RIF
KPN1 >64 R >256 R 16 R >64 R >64 R 0.125 S 4 S 1 S 0.5 S 64 R
KPN2 >64 R >256 R 32 R >64 R 32 R 4 R >128 R 4 S 4 R 64 R
KPN3 >64 R >256 R 32 R >64 R 0.5 S 2 I >128 R 2 S 0.125 S 64 R
MIC minimum inhibitory concentration, R resistant, I intermediate, S susceptible, AMP ampicillin, P/T piperacillin/tazobactam, CTX cefotaxime, CAZ ceftazidime, CPM
cefepime, CIP ciprofloxacin, AMI amikacin, TET tetracycline, IMI imipenem, RIF rifampin
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Analysis of the PFGE patterns showed that the two isolates
carrying blaDHA-1 were closely related (84% similarity).
Discussion
Serotype K1 K. pneumoniae ST23 is, a highly virulent
pathogenic strain causing invasive community-acquired
infections, that is widespread in its geographical distri-
bution in Asia [5]. Fortunately, ST23 strains have shown
good susceptibility to most antibiotics. However, the
advent of multidrug resistance with high transmission
potential in K. pneumoniae serotype K1 causes serious
concerns. A few strains of ESBL-producing serotype K1
K. pneumoniae have already been reported in Asian
countries [6, 7, 11]. In the present study, we report serotype
K1 K. pneumoniae strains co-producing the PAB DHA-1
and ESBL. We found three isolates that were phenotypically
ESBL producers, but we could not detect any bla genes
responsible for the ESBL phenotype. Therefore, other ESBL
genotypes may be involved. In addition, two of the three
isolates were identified as PAB. Recently, gram-negative
organisms that produce both ESBLs and PAB enzymes have
increasingly been described worldwide [12–15]. To our
knowledge, this is the first report of serotype K1 K.
pneumoniae producing both ESBL and PAB. Both ESBLs
and PAB enzymes are associated with broad, multidrug
resistance because multiple antibiotic-resistance genes exist
on the same plasmid [16]. One isolate (KPN3) in our study
showed carbapenem resistance in the broth microdilution
test. Subsequently, we used PCR analysis to determine the
presence of carbapenemase genes, such as blaIMP, blaVIM,
blaOXA, and blaNDM; however, none of these genes were
detected. The frequency of PAB transmission may be
higher than initially thought, especially if the spread of
resistance mimics the trend that we have seen occurring
over the past few years for ESBLs. Moreover, porin
alteration, combined with the production of ESBL or PAB,
has been demonstrated to confer carbapenem resistance
[17, 18]. We also characterized antimicrobial susceptibility
between non-serotype K1 and serotype K1 ESBL-producing
K. pneumoniae. Although the number of total isolates was
too small to draw definite conclusions, the resistant rates of
piperacillin-tazobactam and imipenem in K1 isolates
tended to be high. It is uncertain whether the increase of
antimicrobial resistance in serotype K1 K. pneumoniae is
connected with any one particular resistance gene.
The emergence of multidrug-resistant strains with high
transmission potential in serotype K1 K. pneumoniae is of
great concern due to limited alternative treatment options
and the possibility of global dissemination. Careful surveil-
lance of resistant strains and adequate infection preven-
tion and control measures are necessary.
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